PLATINOL-AQ Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Platinol-aq, and what generic alternatives are available?
Platinol-aq is a drug marketed by Hq Spclt Pharma and is included in one NDA.
The generic ingredient in PLATINOL-AQ is cisplatin. There are fourteen drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the cisplatin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Platinol-aq
A generic version of PLATINOL-AQ was approved as cisplatin by PHARMACHEMIE BV on May 16th, 2000.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PLATINOL-AQ?
- What are the global sales for PLATINOL-AQ?
- What is Average Wholesale Price for PLATINOL-AQ?
Summary for PLATINOL-AQ
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 22 |
Clinical Trials: | 343 |
DailyMed Link: | PLATINOL-AQ at DailyMed |
Recent Clinical Trials for PLATINOL-AQ
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Regeneron Pharmaceuticals | Phase 2 |
AstraZeneca | Phase 3 |
Wuhan Union Hospital, China | Phase 2 |
Pharmacology for PLATINOL-AQ
Drug Class | Platinum-based Drug |
US Patents and Regulatory Information for PLATINOL-AQ
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hq Spclt Pharma | PLATINOL-AQ | cisplatin | INJECTABLE;INJECTION | 018057-003 | Jul 18, 1984 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for PLATINOL-AQ
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Hq Spclt Pharma | PLATINOL-AQ | cisplatin | INJECTABLE;INJECTION | 018057-003 | Jul 18, 1984 | ⤷ Sign Up | ⤷ Sign Up |
Hq Spclt Pharma | PLATINOL-AQ | cisplatin | INJECTABLE;INJECTION | 018057-003 | Jul 18, 1984 | ⤷ Sign Up | ⤷ Sign Up |
Hq Spclt Pharma | PLATINOL-AQ | cisplatin | INJECTABLE;INJECTION | 018057-003 | Jul 18, 1984 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for PLATINOL-AQ
See the table below for patents covering PLATINOL-AQ around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Netherlands | 191108 | ⤷ Sign Up | |
U.S.S.R. | 1192596 | "CПOCOБ ПOЛУЧEHИЯ CTAБИЛЬHOГO PACTBOPA ЦИCПЛATИHA" (METHOD OF PRODUCING STABLE SOLUTION OF CISPLATIN) | ⤷ Sign Up |
Denmark | 149192 | ⤷ Sign Up | |
Canada | 1119954 | SOLUTION AQUEUSE DE CISPLATINE (AQUEOUS SOLUTION OF CISPLATIN) | ⤷ Sign Up |
Sweden | 445172 | STABIL, STERIL VATTENLOSNING AV CISPLATIN I ENHETSDOSERINGSFORM | ⤷ Sign Up |
Malaysia | 8300152 | PHARMACEUTICAL FORMULATIONS CONTAINING CIS-PLATINUM | ⤷ Sign Up |
Spain | 478272 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |